Literature DB >> 3902470

Recombinant murine GM-CSF from E. coli has biological activity and is neutralized by a specific antiserum.

J F DeLamarter, J J Mermod, C M Liang, J F Eliason, D R Thatcher.   

Abstract

We report the production and characterization of a mouse granulocyte-macrophage colony stimulating factor (mGM-CSF) made in Escherichia coli. The synthesis of mGM-CSF was directed by a plasmid containing a gene isolated from the EL-4 cell line. After induction of expression and accumulation of the protein in E. coli, mGM-CSF accounted for 10% of total cellular protein. This recombinant mGM-CSF was purified to 90% homogeneity by chaotrope extraction and gel filtration. Recombinant mGM-CSF, like the native molecule, stimulates the growth of granulocyte and macrophage colonies in serum-free cultures of mouse bone marrow cells. Antibodies raised against recombinant mGM-CSF not only reacted with the recombinant protein but also neutralized the biological activity of both native and recombinant mGM-CSF. These results indicate that the functional structure of the recombinant protein is similar to that of native mGM-CSF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902470      PMCID: PMC554546          DOI: 10.1002/j.1460-2075.1985.tb03973.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells.

Authors:  E R Stanley; P M Heard
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

Review 2.  In vitro synthesis of protein in microbial systems.

Authors:  G Zubay
Journal:  Annu Rev Genet       Date:  1973       Impact factor: 16.830

3.  The growth of mouse bone marrow cells in vitro.

Authors:  T R Bradley; D Metcalf
Journal:  Aust J Exp Biol Med Sci       Date:  1966-06

4.  Improved estimation of secondary structure in ribonucleic acids.

Authors:  I Tinoco; P N Borer; B Dengler; M D Levin; O C Uhlenbeck; D M Crothers; J Bralla
Journal:  Nat New Biol       Date:  1973-11-14

5.  Estimation of secondary structure in ribonucleic acids.

Authors:  I Tinoco; O C Uhlenbeck; M D Levine
Journal:  Nature       Date:  1971-04-09       Impact factor: 49.962

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Purification and properties of colony-stimulating factor from mouse lung-conditioned medium.

Authors:  A W Burgess; J Camakaris; D Metcalf
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

8.  The cloning of normal "mast" cells in tissue culture.

Authors:  D H Pluznik; L Sachs
Journal:  J Cell Physiol       Date:  1965-12       Impact factor: 6.384

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Structure and expression of the mRNA for murine granulocyte-macrophage colony stimulating factor.

Authors:  N M Gough; D Metcalf; J Gough; D Grail; A R Dunn
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  22 in total

1.  Use of a short A/T-rich cassette for enhanced expression of cloned genes in Escherichia coli.

Authors:  D H Mallonee; P B Hylemon
Journal:  Mol Biotechnol       Date:  1999-02       Impact factor: 2.695

2.  Characterization of recombinant-derived granulocyte-colony stimulating factor (G-CSF).

Authors:  P Wingfield; R Benedict; G Turcatti; B Allet; J J Mermod; J DeLamarter; M G Simona; K Rose
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

3.  Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity.

Authors:  C Uyttenhove; R J Simpson; J Van Snick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  A simple and efficient procedure for generating stable expression libraries by cDNA cloning in a retroviral vector.

Authors:  J R Rayner; T J Gonda
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

5.  Autoregulation of interleukin 6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemic cells.

Authors:  Y Shabo; J Lotem; L Sachs
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

6.  Characterization of human and mouse granulocyte-macrophage-colony-stimulating factors derived from Escherichia coli.

Authors:  J L Schrimsher; K Rose; M G Simona; P Wingfield
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

7.  Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation.

Authors:  G E Grau; V Kindler; P F Piguet; P H Lambert; P Vassalli
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

8.  Human Granulocyte-Macrophage Colony-Stimulating Factor Fused to Elastin-Like Polypeptides Assembles Biologically-Active Nanoparticles.

Authors:  Mincheol Park; Vijaya P Vaikari; Jugal P Dhandhukia; Houda Alachkar; J Andrew MacKay
Journal:  Bioconjug Chem       Date:  2020-05-05       Impact factor: 4.774

9.  Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride.

Authors:  R Beyaert; C De Potter; B Vanhaesebroeck; F Van Roy; W Fiers
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

10.  Increased biological activity of deglycosylated recombinant human granulocyte/macrophage colony-stimulating factor produced by yeast or animal cells.

Authors:  P Moonen; J J Mermod; J F Ernst; M Hirschi; J F DeLamarter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.